Instrumental Wealth’s iShares iBonds Dec 2035 Term Corporate ETF IBCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.34M Buy
97,102
+5,315
+6% +$133K 1.13% 14
2026
Q2
$2.35M Buy
91,787
+390
+0.4% +$10K 1.19% 13
2026
Q1
$2.34M Buy
91,397
+674
+0.7% +$17.5K 1.44% 13
2025
Q4
$2.38M Buy
90,723
+9,882
+12% +$257K 1.43% 13
2025
Q3
$2.11M Buy
+80,841
New +$2.08M 1.48% 14

Other funds holding IBCA

Instrumental Wealth's IBCA Position: Q3 2026 in Review

Instrumental Wealth increased its iShares iBonds Dec 2035 Term Corporate ETF (IBCA) stake by 5.8% in Q3 2026, buying an estimated $133K and bringing the position to 97,102 shares worth $2.34M. The position accounts for 1.13% of the portfolio, ranked #14.

Instrumental Wealth first reported a position in IBCA in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.38M in Q4 2025. 28 funds tracked by Wall St. Rank hold IBCA as of Q3 2026.

  • Instrumental Wealth held 97,102 shares of iShares iBonds Dec 2035 Term Corporate ETF worth $2.34M as of Q3 2026.
  • Instrumental Wealth bought 5,315 iShares iBonds Dec 2035 Term Corporate ETF shares in Q3 2026, an estimated $133K.
  • iShares iBonds Dec 2035 Term Corporate ETF made up 1.13% of Instrumental Wealth's portfolio in Q3 2026, its #14 holding.
  • Instrumental Wealth first reported a position in iShares iBonds Dec 2035 Term Corporate ETF in Q3 2025 and has held it in 5 quarters since.
  • Instrumental Wealth's iShares iBonds Dec 2035 Term Corporate ETF position peaked at $2.38M in Q4 2025.
  • 28 funds tracked by Wall St. Rank held iShares iBonds Dec 2035 Term Corporate ETF as of Q3 2026.

Based on Instrumental Wealth's 13F filing for Q3 2026, filed 20 Oct 2026.